Aquestive Long Term Debt from 2010 to 2025
| AQST Stock | USD 3.25 0.04 1.25% |
Long Term Debt | First Reported 2016-12-31 | Previous Quarter 31.3 M | Current Value 32.5 M | Quarterly Volatility 11.4 M |
Check Aquestive Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aquestive Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 10.3 M, Selling General Administrative of 44.5 M or Total Revenue of 49.6 M, as well as many indicators such as Price To Sales Ratio of 3.99, Dividend Yield of 0.0 or Days Sales Outstanding of 63.82. Aquestive financial statements analysis is a perfect complement when working with Aquestive Therapeutics Valuation or Volatility modules.
Aquestive | Long Term Debt |
Latest Aquestive Therapeutics' Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of Aquestive Therapeutics over the last few years. Long-term debt is a debt that Aquestive Therapeutics has held for over one year. Long-term debt appears on Aquestive Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Aquestive Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Aquestive Therapeutics' Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aquestive Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Long Term Debt | 10 Years Trend |
|
Long Term Debt |
| Timeline |
Aquestive Long Term Debt Regression Statistics
| Arithmetic Mean | 37,910,531 | |
| Geometric Mean | 34,972,667 | |
| Coefficient Of Variation | 30.26 | |
| Mean Deviation | 6,980,332 | |
| Median | 38,650,000 | |
| Standard Deviation | 11,473,618 | |
| Sample Variance | 131.6T | |
| Range | 54.4M | |
| R-Value | 0.25 | |
| Mean Square Error | 132.3T | |
| R-Squared | 0.06 | |
| Significance | 0.35 | |
| Slope | 598,602 | |
| Total Sum of Squares | 1974.7T |
Aquestive Long Term Debt History
Other Fundumenentals of Aquestive Therapeutics
Aquestive Therapeutics Long Term Debt component correlations
About Aquestive Therapeutics Financial Statements
Aquestive Therapeutics shareholders use historical fundamental indicators, such as Long Term Debt, to determine how well the company is positioned to perform in the future. Although Aquestive Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Aquestive Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Aquestive Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Long Term Debt | 32.5 M | 41 M | |
| Short and Long Term Debt | 26 K | 24.7 K | |
| Short and Long Term Debt Total | 38 M | 47.7 M | |
| Long Term Debt Total | 54.3 M | 53.8 M | |
| Long Term Debt To Capitalization | (1.65) | (1.57) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aquestive Stock Analysis
When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.